Literature DB >> 24929140

Risk of chronic and end stage kidney disease in patients with nephrolithiasis.

Jonathan Shoag1, Joshua Halpern1, David S Goldfarb2, Brian H Eisner3.   

Abstract

PURPOSE: We examine kidney stone disease as a potential risk factor for chronic kidney disease, end stage kidney disease and treatment with dialysis.
MATERIALS AND METHODS: The NHANES (National Health and Nutrition Examination Survey) 2007-2010 database was interrogated for patients with a history of kidney stones. Demographics and comorbid conditions including age, gender, body mass index, diabetes, hemoglobin A1c, hypertension, gout and smoking were also assessed. Multivariate analysis adjusting for patient demographics and comorbidities was performed to assess differences in the prevalence of chronic kidney disease and treatment with dialysis between the 2 groups. History of nephrolithiasis was assessed with the question, "Have you ever had kidney stones?" Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml/minute/1.73 m(2) and/or a urinary albumin-to-creatinine ratio greater than 30 mg/gm. Statistical calculations were performed using Stata® software with determinations of p values and 95% CI where appropriate.
RESULTS: The study included an analysis of 5,971 NHANES participants for whom data on chronic kidney disease and kidney stones were available, of whom 521 reported a history of kidney stones. On multivariate analysis a history of kidney stones was associated with chronic kidney disease and treatment with dialysis (OR 1.50, 1.10-2.04, p = 0.013 and OR 2.37, 1.13-4.96, p = 0.025, respectively). This difference appeared to be driven by women, where a history of kidney stones was associated with a higher prevalence of chronic kidney disease (OR 1.76, 1.13-2.763, p = 0.016) and treatment with dialysis (OR 3.26, 1.48-7.16, p = 0.004). There was not a significant association between kidney stone history and chronic kidney disease or treatment with dialysis in men.
CONCLUSIONS: Kidney stone history is associated with an increased risk of chronic kidney disease and treatment with dialysis among women even after adjusting for comorbid conditions. Large scale prospective studies are needed to further characterize the relationship between nephrolithiasis and chronic kidney disease.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic; dialysis; epidemiology; kidney calculi; kidney failure; urolithiasis

Mesh:

Year:  2014        PMID: 24929140     DOI: 10.1016/j.juro.2014.05.117

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  38 in total

1.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

2.  Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.

Authors:  Tsering Dhondup; Wonngarm Kittanamongkolchai; Lisa E Vaughan; Ramila A Mehta; Jasdeep K Chhina; Felicity T Enders; LaTonya J Hickson; John C Lieske; Andrew D Rule
Journal:  Am J Kidney Dis       Date:  2018-08-23       Impact factor: 8.860

3.  Kidney Function After the First Kidney Stone Event.

Authors:  William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule
Journal:  Mayo Clin Proc       Date:  2016-10-21       Impact factor: 7.616

4.  Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants.

Authors:  Meng Zhe; Zheng Hang
Journal:  Urolithiasis       Date:  2016-11-11       Impact factor: 3.436

5.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

6.  Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.

Authors:  Jennifer Williams; Ross P Holmes; Dean G Assimos; Tanecia Mitchell
Journal:  Urology       Date:  2016-03-10       Impact factor: 2.649

Review 7.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

Review 8.  Risks of flexible ureterorenoscopy: pathophysiology and prevention.

Authors:  Palle J S Osther
Journal:  Urolithiasis       Date:  2017-11-18       Impact factor: 3.436

9.  Shock wave lithotripsy does not impair renal function in a Swine model of metabolic syndrome.

Authors:  Rajash K Handa; Cynthia D Johnson; Bret A Connors; Andrew P Evan; Carrie L Phillips; Ziyue Liu
Journal:  J Endourol       Date:  2014-11-18       Impact factor: 2.942

10.  The kidney stone and increased water intake trial in steel workers: results from a pilot study.

Authors:  Yair Lotan; Jodi Antonelli; Inmaculada Buendia Jiménez; Hakam Gharbi; Ron Herring; Allison Beaver; Aphrihl Dennis; Dendra Von Merveldt; Suzie Carter; Adam Cohen; John Poindexter; Orson W Moe; Margaret S Pearle
Journal:  Urolithiasis       Date:  2016-05-26       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.